Skip to main content

Table 5 Number of patients measured per omics for each cancer type. Total: Number of patients measured for at least one omics (of which those having been measured for the three omics); proportion of partial data; Exp+Met: Patients measured for expression and methylation only; Exp+miRNA: Patients measured for expression and miRNA only; Met+miRNA: Patients measured for methylation and miRNA only; Exp: Patients measured for expression only; Met: Patients measured for methylation only; miRNA: Patients measured for miRNA only

From: Consensus clustering applied to multi-omics disease subtyping

Cancer Total (multi-omic) % partial data Exp+ Met Exp+ miRNA Met+ miRNA Exp Met miRNA
AML 197 (170) 13.71 0 3 15 0 9 0
BIC 1096 (621) 43.34 159 132 2 181 1 0
COAD 303 (220) 27.39 57 0 0 8 18 0
GBM 578 (274) 52.60 4 245 3 5 4 43
KIRC 534 (183) 65.73 135 71 0 144 1 0
LIHC 377 (367) 2.65 4 0 5 0 1 0
LUSC 501 (341) 31.94 29 1 0 130 0 0
OV 591 (287) 51.44 7 0 166 9 122 0
SARC 261 (257) 1.53 2 0 2 0 0 0
SKCM 368 (351) 4.62 16 1 0 0 0 0